Profile data is unavailable for this security.
About the company
Medical Compression System DBN Ltd is an Israel-based company active in the medical sector. It is engaged in the research, development, production and marketing of non-invasive and non-medicinal solutions to improve the blood flow processes, using a pneumatic device which places pressure on the limbs by means of compressed air. The technology developed by the Company facilitates reducing the risk of blood clots forming during traumatic and surgical events, and secular diseases. It also completed the development of a pneumatic device for preventing the formation of blood clots in the deep veins system as the result of a trauma or surgical intervention, which is called the ActiveCare DVT.
- Revenue in ILS (TTM)14.41m
- Net income in ILS-9.73m
- Incorporated1997
- Employees47.00
- LocationPharmocann Global LtdHORESH HA'ALONIMRAMAT IYSHAYI 3009500IsraelISR
- Phone+972 49533757
- Fax+972 49533756
- Websitehttps://pharmocann.co.il/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Univo Pharmaceuticals Ltd | 52.65m | -32.19m | 3.06m | 12.00 | -- | 0.1744 | -- | 0.0582 | -10,833.61 | -10,833.61 | 18,078.28 | 5,333.01 | 0.6406 | 2.15 | 20.71 | -- | -39.71 | -40.93 | -58.86 | -53.86 | 28.88 | -- | -61.99 | -95.67 | 0.6479 | -4.90 | 0.6719 | -- | 25.38 | 170.24 | -3,522.40 | -- | 428.61 | -- |
| HBL Hadasit Bio Holdings Ltd | 0.00 | -29.19m | 4.21m | 16.00 | -- | 0.7097 | -- | -- | -2.63 | -2.63 | 0.00 | 0.5354 | 0.00 | -- | -- | -- | -124.15 | -13.00 | -137.60 | -13.91 | -- | -- | -- | -100,517.40 | -- | -0.065 | 0.2098 | -- | -- | -- | 6.48 | -- | -- | -- |
| Plantarc Bio Ltd | 4.78m | -2.11m | 8.44m | -- | -- | 0.7057 | -- | 1.77 | -0.6359 | -0.6359 | 1.44 | 3.61 | 0.3363 | -- | 13.48 | -- | -14.84 | -37.73 | -16.44 | -41.77 | 61.43 | -- | -44.12 | -376.62 | -- | -- | 0.0059 | -- | -- | -- | 57.69 | -- | 111.75 | -- |
| Flying Spark Ltd | 16.00k | -11.47m | 9.12m | -- | -- | -- | -- | 569.70 | -1.84 | -1.84 | 0.0022 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -218.75 | -- | -71,731.25 | -- | -- | -41.04 | -- | -- | 71.43 | -- | -248.13 | -- | -- | -- |
| Pharmocann Global Ltd | 14.41m | -9.73m | 10.21m | 47.00 | -- | 11.68 | -- | 0.7083 | -5.34 | -5.34 | 7.32 | 0.3416 | 1.14 | 3.51 | 6.93 | -- | -77.32 | -60.73 | -170.19 | -74.16 | -9.51 | 23.70 | -67.54 | -84.62 | 0.704 | -82.20 | 0.3394 | -- | -36.38 | -0.4935 | 61.46 | -- | -51.49 | -- |
| Millennium Food-Tech LP | 464.00k | -25.91m | 16.19m | 2.00 | -- | 0.144 | -- | 34.89 | -0.9204 | -0.9204 | 0.018 | 3.44 | 0.0038 | -- | 3.40 | 232,000.00 | -21.38 | -- | -21.52 | -- | -- | -- | -5,584.27 | -- | -- | -0.17 | 0.00 | -- | 224.48 | -- | -84.01 | -- | -- | -- |
| Kadimastem Ltd | 0.00 | -12.01m | 21.02m | 32.00 | -- | -- | -- | -- | -1.22 | -1.22 | 0.00 | -1.04 | 0.00 | -- | -- | -- | -115.17 | -155.33 | -1,153.60 | -1,831.12 | -- | -- | -- | -- | -- | -9.44 | 3.22 | -- | -- | -- | 47.14 | -- | -50.73 | -- |
| Nextage Therapeutics Ltd | 876.00k | -4.07m | 22.51m | -- | -- | -- | -- | 25.70 | -0.1396 | -0.1396 | 0.03 | -0.0958 | 0.672 | -- | 6.82 | -- | -322.44 | -188.94 | -- | -423.76 | 25.68 | 33.33 | -479.79 | -2,486.19 | -- | -18.46 | -- | -- | -- | 17.99 | 27.21 | -- | -- | -- |
| Tikun Olam Cannbit Pharmaceuticals Ltd | 44.23m | -88.89m | 31.44m | 51.00 | -- | 0.7325 | -- | 0.7108 | -1.43 | -1.43 | 0.7018 | 0.5051 | 0.379 | 2.87 | 19.85 | 867,215.70 | -80.56 | -30.17 | -99.81 | -35.04 | -0.4273 | -- | -212.57 | -146.42 | 0.5033 | -30.02 | 0.3778 | -- | -10.28 | -- | -84.28 | -- | -8.71 | -- |
| Can Fite Biopharma Ltd | 2.75m | -28.30m | 40.58m | 5.00 | -- | 1.59 | -- | 14.73 | -0.0225 | -0.0225 | 0.0022 | 0.017 | 0.0771 | -- | -- | 550,949.40 | -79.22 | -102.29 | -103.51 | -131.07 | -- | -- | -1,027.46 | -1,105.36 | -- | -- | 0.00 | -- | -8.27 | -27.92 | 24.96 | -- | -42.92 | -- |
| Wilk Technologies Ltd | 0.00 | -10.93m | 42.74m | 4.00 | -- | 6.18 | -- | -- | -0.1807 | -0.1807 | 0.00 | 0.1006 | 0.00 | -- | -- | -- | -80.10 | -266.55 | -96.15 | -298.65 | -- | -- | -- | -97,340.88 | -- | -39.62 | 0.4049 | -- | -- | -- | 36.02 | -- | -- | -- |
| Grace Breeding Ltd | 463.00k | -8.50m | 44.22m | -- | -- | 27.89 | -- | 95.51 | -2.36 | -2.25 | 0.1296 | 0.3998 | 0.0848 | 2.73 | 0.9636 | -- | -164.09 | -- | -206.24 | -- | 80.56 | -- | -1,935.21 | -- | 1.45 | -94.74 | 0.5103 | -- | 121.53 | -- | 23.10 | -- | -- | -- |
Data as of Jun 02 2024. Currency figures normalised to Pharmocann Global Ltd's reporting currency: Israeli Shekel ILS
1.07%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Meitav Mutual Funds Ltd.as of 29 Feb 2024 | 26.13k | 1.07% |
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
